📋 Why did Biden repeal Trump's Executive Order - December 29, 2022

To win the battle for what The Nobel Laureate Committee called the "Holy Grail" of medicine.

Unsubscribe | View in browser Rich People Trades is dedicated to providing readers like you with unique opportunities. The message below from one of our business associates is one we believe you should take a serious look at. Dear Fellow Investor, Within 10 days of taking office, President Trump signed "Executive Order 13771." He wanted us to win the war for the future of medicine! To win the battle for what 60 minutes said could be "the most consequential discovery in biomedicine this century." To win the battle for what The Nobel Laureate Committee called the "Holy Grail" of medicine. This breakthrough technology has the ability to eliminate all 6,000 genetic diseases from mankind. Diseases like skin cancer, liver disease, and diabetes... And as a result, this technology could create more millionaires than any other single breakthrough in history. So why did Biden repeal this? Click here to learn more >>> All the best, Simmy Adelman Editor, Behind the Markets Email sent by Finance and Investing Traffic, LLC, owner and operator of Rich People Trades    You showed interest in the niche of financial education on one of our signup forms or landing pages.   Investing involves substantial risk. Neither the Editor, the publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from using the Newsletter.   This ad is sent on behalf of Behind The Markets, 4260 NW 1st Avenue, Suite # 55 Boca Raton, FL 33431 – 4264. If you would like to unsubscribe from receiving offers from Behind The Markets please click here.   If you received this email by mistake, please let us know at this email address abuse@richpeopletrades.com. You'll receive a response within 24 hours.   To make sure you don't miss any of our contents, be sure to whitelist us.   221 W 9th St # Wilmington, DE 19801   © 2022 RichPeopleTrades.com. All Rights Reserved.   Privacy Policy | Terms & Conditions | Unsubscribe